Admira MR 30 mg is an oral antidiabetic medication manufactured by Unimed Unihealth Pharmaceuticals Ltd.. It contains Gliclazide, a second-generation sulfonylurea used to manage type 2 diabetes mellitus in adults. This medication aids in controlling blood sugar levels, thereby reducing the risk of complications associated with diabetes, such as nerve damage, kidney problems, and heart disease.